Helen E. Jo

1.7k total citations
31 papers, 606 citations indexed

About

Helen E. Jo is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Helen E. Jo has authored 31 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 4 papers in Epidemiology. Recurrent topics in Helen E. Jo's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Pulmonary Hypertension Research and Treatments (8 papers). Helen E. Jo is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Pulmonary Hypertension Research and Treatments (8 papers). Helen E. Jo collaborates with scholars based in Australia, United Kingdom and United States. Helen E. Jo's co-authors include Yuben Moodley, Ian Glaspole, Tamera J. Corte, Nicole Goh, Paul N. Reynolds, Christopher Grainge, Samantha Ellis, Wendy A. Cooper, Sally Chapman and Tamera J. Corte and has published in prestigious journals such as European Respiratory Journal, International Journal of Nanomedicine and Respiratory Medicine.

In The Last Decade

Helen E. Jo

28 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen E. Jo Australia 13 577 240 55 54 48 31 606
Olivia Freynet France 11 393 0.7× 229 1.0× 67 1.2× 24 0.4× 36 0.8× 28 459
Konstantinos Kagouridis Greece 11 443 0.8× 118 0.5× 70 1.3× 28 0.5× 19 0.4× 19 485
Carlos Aravena Chile 12 689 1.2× 293 1.2× 40 0.7× 109 2.0× 70 1.5× 28 796
Mark Edwin United States 4 777 1.3× 244 1.0× 104 1.9× 74 1.4× 63 1.3× 7 853
Judit Axmann United Kingdom 6 566 1.0× 252 1.1× 75 1.4× 53 1.0× 68 1.4× 11 594
Kaïs Ahmad France 7 344 0.6× 131 0.5× 97 1.8× 40 0.7× 31 0.6× 15 413
Rebecca L. Mortenson United States 8 484 0.8× 184 0.8× 82 1.5× 23 0.4× 44 0.9× 9 535
Chikatoshi Sugimoto Japan 13 403 0.7× 147 0.6× 65 1.2× 39 0.7× 48 1.0× 47 486
Janelle Vu Pugashetti United States 10 391 0.7× 135 0.6× 69 1.3× 30 0.6× 27 0.6× 30 433
Masashi Mikamo Japan 13 378 0.7× 210 0.9× 39 0.7× 12 0.2× 17 0.4× 19 426

Countries citing papers authored by Helen E. Jo

Since Specialization
Citations

This map shows the geographic impact of Helen E. Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Jo more than expected).

Fields of papers citing papers by Helen E. Jo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen E. Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Jo. The network helps show where Helen E. Jo may publish in the future.

Co-authorship network of co-authors of Helen E. Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Helen E. Jo. A scholar is included among the top collaborators of Helen E. Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen E. Jo. Helen E. Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations
2.
Yang, Nan, Francesco Federico, Stephen M. Humphries, et al.. (2025). Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. European Respiratory Journal. 66(4). 2500981–2500981.
3.
Jung, Young Hyun, et al.. (2025). Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer’s Disease and Parkinson’s Disease. International Journal of Nanomedicine. Volume 20. 4903–4917. 2 indexed citations
4.
Mackintosh, John A., Gregory J. Keir, Lauren Troy, et al.. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 29(2). 105–135. 26 indexed citations
5.
Harrison, Megan, Helen E. Jo, Lauren Troy, et al.. (2024). Disease Behaviour Classification: A pragmatic model for predicting outcomes in Interstitial Lung Disease. Respiratory Medicine. 224. 107533–107533. 1 indexed citations
6.
Spencer, Lissa, Jennifer Alison, Susanne Webster, et al.. (2024). The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respiratory Medicine. 232. 107748–107748. 2 indexed citations
7.
Dwyer, Tiffany, Michelle Cunich, Ruth Dentice, et al.. (2023). Impact of cystic fibrosis multidisciplinary virtual clinics on patient experience, time commitments and costs. Internal Medicine Journal. 54(5). 809–816. 1 indexed citations
8.
Jo, Helen E., et al.. (2022). ELX/TEZ/IVA use in cystic fibrosis liver disease: Is the perspective of improved lung function worth the risk?. Journal of Cystic Fibrosis. 21(5). 881–884. 1 indexed citations
9.
Jee, Adelle S., Matthew Parker, Jane Bleasel, et al.. (2021). Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay. Respiratory Medicine. 187. 106581–106581. 4 indexed citations
10.
Jee, Adelle S., Matthew Parker, Jane Bleasel, et al.. (2021). Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort. Respiration. 100(9). 853–864. 13 indexed citations
11.
Brereton, Christopher J. & Helen E. Jo. (2020). Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids. Breathe. 16(3). 200086–200086. 8 indexed citations
12.
McLean, Anna, Susanne Webster, Margaret Fry, et al.. (2020). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology. 26(1). 80–86. 11 indexed citations
13.
Wrobel, Jérémy, Jessica Rhodes, Susanne Webster, et al.. (2020). Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database. BMC Pulmonary Medicine. 20(1). 257–257. 16 indexed citations
14.
Jo, Helen E., Tamera J. Corte, Ian Glaspole, et al.. (2019). Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulmonary Medicine. 19(1). 84–84. 22 indexed citations
15.
Jo, Helen E., Ian Glaspole, Christopher Grainge, et al.. (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal. 49(2). 1601592–1601592. 161 indexed citations
16.
Phan, Kevin, Helen E. Jo, Joshua Xu, & Edmund Lau. (2017). Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis. Heart Lung and Circulation. 27(1). 89–98. 29 indexed citations
17.
Jo, Helen E., Tamera J. Corte, Stephen J. Wort, et al.. (2016). Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease. Respirology. 21(3). 556–566. 2 indexed citations
18.
Jo, Helen E., Tamera J. Corte, Yuben Moodley, et al.. (2016). Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres. BMC Pulmonary Medicine. 16(1). 22–22. 25 indexed citations
19.
Jo, Helen E., et al.. (2016). Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations. Drugs & Aging. 33(5). 321–334. 52 indexed citations
20.
Jo, Helen E., Ricardo Russo, Mark Pearson, Elizabeth Veitch, & Matthew Peters. (2013). Predicting survival in interstitial lung disease: the role of DTPA lung clearance scans. Respirology. 18. 72–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivia Freynet Breakdown of academic impact, for papers by Konstantinos Kagouridis Breakdown of academic impact, for papers by Carlos Aravena Breakdown of academic impact, for papers by Mark Edwin Breakdown of academic impact, for papers by Judit Axmann Breakdown of academic impact, for papers by Kaïs Ahmad Breakdown of academic impact, for papers by Rebecca L. Mortenson Breakdown of academic impact, for papers by Chikatoshi Sugimoto Breakdown of academic impact, for papers by Janelle Vu Pugashetti Breakdown of academic impact, for papers by Masashi Mikamo
Rankless by CCL
2026